SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Silver Spike Investment Corp. SSIC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Silver Spike Investment Corp. (SSIC) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $10.74. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 2 out of 7 criteria passed.

Financials: revenue is $54.3B, +61689.3%/yr average growth. Net profit margin is 0% (thin). Gross margin is 0% (-100 pp trend).

Balance sheet: total debt is $25.0B against $303.4B equity (Debt-to-Equity (D/E) ratio 0.08, conservative). Current ratio is 0.24 (tight liquidity). Debt-to-assets is 7.3%. Total assets: $342.0B.

Analyst outlook: 2 / 3 analysts rate SSIC as buy (67%) — moderate consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 33/100 (Fail), Moat 20/100 (Fail), Future 55/100 (Partial), Income 30/100 (Fail).

SSIC SharesGrow Score Overview

55/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 50/100

strong — trend

HEALTH 33/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 20/100

Gross margin is + market cap

FUTURE 55/100

Analyst outlook — as buy

INCOME 30/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SSIC

SSIC trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SSIC: +61689.3%/yr revenue is, +114.9%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SSIC: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SSIC: Debt-to-Equity (D/E) ratio 0.08 (conservative), Current ratio is 0.24 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SSIC: Gross margin is 0% (-100 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 20/100. ≥ 70 = Pass.

View details →

Analyst outlook: 2 / 3 analysts rate SSIC as buy (67%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SSIC: Net profit margin is 0%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range7.29-12.97

Volume5.82K

Avg Volume (30D)8.78K

Market Cap$66.72M

Beta (1Y)0.28

Dividend Yield$1.0000

Share Statistics

EPS (TTM)1.45

Shares Outstanding$22.82M

IPO Date2022-02-04

CEOScott Charles Gordon

Financial Highlights & Ratios

Revenue (TTM)$54.3B

Total Cash$2.93B

Total Debt$25B

Net Debt$22.07B

Total Assets$342B

Price / Earnings (P/E)7.4

Price / Sales (P/S)0

Analyst Forecast

Rating ConsensusBuy

Analysts Covering3

Buy 67% Hold 33% Sell 0%

Company Info

CountryUS

ExchangeNASDAQ Global Market

CurrencyUSD

ISINUS8281741020

Price Chart

SSIC

Silver Spike Investment Corp. ↗ · NASDAQ Global Market

Healthcare • Drug Manufacturers - Specialty & Generic

7.29 52WK RANGE 12.97

People Also View

RAMM Pharma Corp.

City View Green Holdings Inc.

Pure Harvest Corporate Group, Inc.

Entourage Health Corp.

Speakeasy Cannabis Club Ltd.

RavenQuest BioMed Inc.

Craftport Cannabis Corp.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message